Clinical Trial Update: Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

Phase 2 trial update on using eflornithine to prevent cervical cancer in patients with cervical intraepithelial neoplasia (precancerous condition).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Eflornithine (eflornithine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cervical Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED